LLY241129P1100000
- 0.00
- 0.000.00%
Eli Lilly and Co Newsroom
S&P 500, Dow Hit Records Right After Open | Live Stock
Hong Kong Stock Market News | Lai Kai Pharmaceuticals-B (02105) rose more than 22%, hitting a new high for the year. Recently announced clinical cooperation with eli lilly and co on a new type of weight loss drug.
The stock price of Lai Kai Pharmaceutical-B (02105) rose by over 22%, reaching a high of HK$17.4, setting a new high for the year. As of the time of publication, it has increased by 22.48%, trading at HK$17, with a turnover of 0.178 billion Hong Kong dollars.
Eli Lilly's (LLY) Breakthroughs: Hedge Funds' New Healthcare Favorite
Jim Cramer on Eli Lilly and Company (LLY): 'It's Valuable'
Trump Nominates Marty Makary For FDA Commissioner
The Trader: Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop -- Barron's
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Sanofi Becomes Latest Drugmaker to Challenge HHS Over 340B Drug-discount Program
Market Climbs, Bitcoin Close to $100k | Live Stock
novo-nordisk a/s (NVO.US) has signed a contract with Ypsomed to produce the next generation of injection pens for weight loss medication.
novo-nordisk a/s has announced that it has signed a contract with Ypsomed to produce the next generation of weight loss pen.
Novo Nordisk Said to Have Contracted Ypsomed to Make Next Gen Obesity Drug's Pens
Goldman Sachs: Eli Lilly and Company (LLY) Is A Top Growth Investor Stock
Amgen (AMGN.US) weight loss drug is poised to launch, and Wall Street is eagerly awaiting the research results.
Amgen (AMGN.US) will soon release mid-term study data for the experimental weight loss drug MariTide, revealing a comparison of this drug with GLP-1 drugs from Eli Lilly (LLY.US) and novo-nordisk A/S (NVO.US).
In 2025, the global medical care industry is expected to usher in an investment boom, with a focus on Biotech.
Jefferies financial indicated that investor sentiment in the global medical care industry has significantly warmed up.
Express News | Shares Of Hims & Hers Health See Volume; Traders Circulate Court Filing Regarding Shortage Of Lilly's Tirzepatide Shortage, Parties Agree To Maintain Stay As Ordered By Court In October 2024, With Joint Status Report Due By December 19, 2024, Or...
Bitcoin Hits $99k, Thursday Market Whiplash Following Nvidia Price | Wall Street Today
Hims & Hers Closes up 10% as Lilly Tirzepatide Compounding Dispute Resolution Delayed
Optimism Over Global Healthcare Sector Rises: Jefferies
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs